VENOM Explains Lack Of U.S. Shows: Getting Visas Is 'Really Expensive' And 'So Difficult'

Why It Matters

The visa and cost barriers limit revenue and fan engagement for legacy metal acts, illustrating how U.S. immigration policy can reshape the live‑music landscape. This challenges promoters and artists seeking to tap the lucrative American market.

Key Takeaways

• Visa fees cost $7k‑$9k for three‑member Venom tour
• Visa process requires multiple interviews, no guarantee of approval
• Rising bus costs make U.S. tours financially risky for big bands
• Multiple Venom lineups and a copyright lawsuit complicate brand
• Legacy metal acts face growing barriers to U.S. live market

Pulse Analysis

The United Kingdom’s most influential black‑metal outfit, Venom, has laid bare the financial and bureaucratic hurdles that now dominate transatlantic touring. A standard P‑1 performance visa, once a routine paperwork item, now carries a fee of $7,000 to $9,000 for a three‑person band, plus a series of three interviews at the U.S. embassy. Even after paying the fee, approval is not guaranteed, and the process can consume days of embassy time. For a group that relies on global fan bases, these added costs erode profit margins and force promoters to reconsider booking dates, especially when the alternative—tour‑bus rentals—have also surged beyond historic rates.

Beyond visas, Venom’s situation reflects a broader shift in the live‑music ecosystem. The U.S. market, long considered the pinnacle for touring revenue, is becoming less accessible to legacy acts whose touring budgets are already stretched by production values and crew expenses. Smaller, underground bands are adapting by using RVs or chartered vans, but larger, established groups face a dilemma: either absorb the heightened costs or forgo the market altogether. This dynamic is prompting industry stakeholders to explore alternative visa categories, such as the O‑1 for individuals with extraordinary ability, and to negotiate with promoters for shared risk models.

Complicating matters for Venom is an internal legal battle over its iconic logo, with a copyright lawsuit pitting founding member Cronos against former drummer Abaddon. The dispute, coupled with the existence of three separate touring entities under the Venom name, fragments brand equity and makes coordinated U.S. marketing efforts more complex. As immigration policies tighten and operational costs rise, the band’s experience serves as a cautionary tale for other veteran acts: without strategic legal and logistical planning, even a global fanbase may not translate into a viable American tour.